Have a personal or library account? Click to login
Are Lactobacillus Bulgaricus and Bacillus Calmette-Guérin vaccine suitable for patient protection against SARS-CoV-2 infection? Cover

Are Lactobacillus Bulgaricus and Bacillus Calmette-Guérin vaccine suitable for patient protection against SARS-CoV-2 infection?

Romanian Journal of Rhinology
Volume 11 (2021): Issue 43 (September 2021)
By: Toma Avramov,  Dilyana Vicheva and  Antoaneta Manolova  
Open Access
|Jul 2021

Authors

Toma Avramov

toma_avramov@abv.bg

Medical University, ENT Clinic, “Tzaritsa Yoanna-ISUL” University Hospital, Sofia, Bulgaria

Dilyana Vicheva

Department of Otorhinolaryngology, Medical Faculty, Medical University, Plovdiv, Bulgaria

Antoaneta Manolova

National Center for Public Health and Analysis, Sofia, Bulgaria
DOI: https://doi.org/10.2478/rjr-2021-0018 | Journal eISSN: 2393-3356 | Journal ISSN: 2069-6523
Journal RSS Feed
Language: English
Page range: 101 - 110
Submitted on: Apr 4, 2021
|
Accepted on: May 20, 2021
|
Published on: Jul 31, 2021
Published by: Romanian Rhinologic Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Lactobacillus,
BCG vaccine,
emerging coronavirus,
SARS-CoV-2,
viral entry
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Surgery,
Surgery, other,
Otorhinolaryngology,
Speech, voice and paediatric hearing disorders,
Oromaxillofacial surgery

© 2021 Toma Avramov, Dilyana Vicheva, Antoaneta Manolova, published by Romanian Rhinologic Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 11 (2021): Issue 43 (September 2021)Next article